Liu Dan, Zhang Xiao-Xue, Xi Bi-Xin, Wan Dong-Yi, Li Li, Zhou Jin, Wang Wei, Ma Ding, Wang Hui, Gao Qing-Lei
Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P.R. China.
Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University Guangzhou, Guangzhou, P.R. China.
Int J Oncol. 2014 Sep;45(3):1232-40. doi: 10.3892/ijo.2014.2510. Epub 2014 Jun 20.
Malignant proliferation is the fundamental trait of tumor cells. The initiation of DNA replication represents a key process for cell proliferation, and has a marked impact on tumorigenesis and progression. Here we report that Sine oculis homeobox homolog 1 (SIX1) functions as a master regulator in DNA replication of cervical cancer cells. The expression of SIX1 was induced by the E7 oncoprotein of human papillomaviruses in cervical intraepithelial neoplasia and cervical cancer. The increase of SIX1 expression resulted in the upregulation of multiple genes related to the initiation of DNA replication, including the genes coding for the proteins in minichromosome maintenance complex (MCM2, MCM3, MCM6), DNA polymerase α-primase complex (POLA1, PRIM1, PRIM2), clamp loader (RFC3, RFC4, RFC5), DNA polymerase δ complex (POLD3) and DNA polymerase ε complex (POLE2). In line with this, the increase of SIX1 expression enhanced DNA synthesis, accelerated G1 to S phase progression, and promoted the proliferation of cervical cancer cells and the growth of cervical cancer. Consistently, knockdown of SIX1 could hamper DNA synthesis, slow down G1 to S phase progression, and suppress tumor cell proliferation and tumor growth. Importantly, SIX1 could more efficiently promote anchorage-independent cell growth. These results suggest that the increase of SIX1 expression could promote tumorigenesis, progression and invasive growth of cervical cancer by promoting DNA replication, and that targeting SIX1 may have significant therapeutic value in cervical cancer treatment.
恶性增殖是肿瘤细胞的基本特征。DNA复制的起始是细胞增殖的关键过程,对肿瘤发生和进展有显著影响。在此,我们报告眼缺失同源盒1(SIX1)在宫颈癌细胞的DNA复制中起主要调节作用。在宫颈上皮内瘤变和宫颈癌中,人乳头瘤病毒的E7癌蛋白可诱导SIX1的表达。SIX1表达的增加导致多个与DNA复制起始相关基因的上调,包括编码微小染色体维持复合物(MCM2、MCM3、MCM6)、DNA聚合酶α-引发酶复合物(POLA1、PRIM1、PRIM2)、钳位装载器(RFC3、RFC4、RFC5)、DNA聚合酶δ复合物(POLD3)和DNA聚合酶ε复合物(POLE2)中蛋白质的基因。与此一致,SIX1表达的增加增强了DNA合成,加速了G1期到S期的进程,并促进了宫颈癌细胞的增殖和宫颈癌的生长。同样,敲低SIX1可阻碍DNA合成,减缓G1期到S期的进程,并抑制肿瘤细胞增殖和肿瘤生长。重要的是,SIX1能更有效地促进非锚定依赖性细胞生长。这些结果表明,SIX1表达的增加可通过促进DNA复制来促进宫颈癌的发生、进展和侵袭性生长,靶向SIX1在宫颈癌治疗中可能具有重要的治疗价值。